Business profile not generated.
Run python -m application.cli.business_profile run --market US --one MGX, then regenerate the site.
Issue 000 | U.S. Pilot | US
MGX
Metagenomi Therapeutics, Inc.
Passing
Verified
10-Q | 2026-05-11
Filing currency: USD
Margin of Safety
44.4%
GNNI internal calculation. Market context inputs are retained internally and are not displayed.
- Current Assets
- 144,558,000USD
- Total Liabilities
- 59,168,000USD
- NCAV
- 85,390,000USD
- Cash
- 25,306,000USD
- NCAV per share
- 2.27USD/share
- Evidence
- 3 annual | 9 quarterly
Business Profile
Checklist-driven facts extracted from filing text. Missing fields stay visible.
Known Unknowns
Only 9 quarterly periods available from Data Vault for this company.
Medium | Share Count
Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.
Low | Classification
U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.
Annual Financials
Latest annual periods, newest first. Missing cells render as n/a.
| Metric |
2025-12-31
10-K
USD
|
2024-12-31
10-K
USD
|
2023-12-31
10-K
USD
|
|---|---|---|---|
| Revenue | 25,210,000 | 52,295,000 | 44,756,000 |
| Operating Income | -96,013,000 | -88,901,000 | -78,492,000 |
| Net Income | -87,868,000 | -78,058,000 | -68,255,000 |
| Cash From Operations | -88,892,000 | -109,073,000 | -91,409,000 |
| Capex | -574,000 | -3,114,000 | -9,814,000 |
| Free Cash Flow | -89,466,000 | -112,187,000 | -101,223,000 |
| Cash And Equivalents | 41,722,000 | 27,386,000 | 140,603,000 |
| Accounts Receivable | 305,000 | 1,257,000 | 2,451,000 |
| Inventory | n/a | n/a | n/a |
| Total Current Assets | 165,538,000 | 257,960,000 | 278,273,000 |
| Total Assets | 221,103,000 | 324,599,000 | 364,842,000 |
| Total Current Liabilities | 22,933,000 | 37,309,000 | 68,861,000 |
| Total Liabilities | 62,507,000 | 89,742,000 | 149,668,000 |
| Shareholders Equity | 158,596,000 | 234,857,000 | -135,584,000 |
| Shares Outstanding | 37,620,668 | 37,418,470 | 3,404,585 |
| Shares Outstanding Diluted | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 37,251,050 | 33,027,889 | 3,404,585 |
| Weighted Avg Shares Basic | 37,251,050 | 33,027,889 | 3,404,585 |
Quarterly Financials
Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.
Only 9 quarterly periods available from Data Vault for this company.
| Metric |
2026-03-31
10-Q
USD
|
2025-12-31
10-K
USD
|
2025-09-30
10-Q
USD
|
2025-06-30
10-Q
USD
|
2025-03-31
10-Q
USD
|
2024-12-31
10-K
USD
|
2024-09-30
10-Q
USD
|
2024-06-30
10-Q
USD
|
2024-03-31
10-Q
USD
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,248,000 | 3,911,000 | 8,659,000 | 8,513,000 | 4,127,000 | 9,614,000 | 11,514,000 | 20,008,000 | 11,159,000 |
| Operating Income | -24,587,000 | -24,367,000 | -22,839,000 | -20,987,000 | -27,820,000 | -20,623,000 | -22,383,000 | -16,863,000 | -29,032,000 |
| Net Income | -23,059,000 | -22,528,000 | -20,393,000 | -19,908,000 | -25,039,000 | -23,398,000 | -18,773,000 | -10,739,000 | -25,148,000 |
| Cash From Operations | -21,175,000 | -23,546,000 | -21,253,000 | -21,251,000 | -22,842,000 | -26,276,000 | -26,638,000 | -26,309,000 | -29,850,000 |
| Capex | -25,000 | -85,000 | -74,000 | -127,000 | -288,000 | -334,000 | -1,200,000 | -665,000 | -915,000 |
| Free Cash Flow | -21,200,000 | -23,631,000 | -21,327,000 | -21,378,000 | -23,130,000 | -26,610,000 | -27,838,000 | -26,974,000 | -30,765,000 |
| Cash And Equivalents | 25,306,000 | 41,722,000 | 32,773,000 | 26,850,000 | 29,195,000 | 27,386,000 | 25,117,000 | 61,181,000 | 102,558,000 |
| Total Current Assets | 144,558,000 | 165,538,000 | 189,820,000 | 211,681,000 | 233,195,000 | 257,960,000 | 282,293,000 | 307,579,000 | 335,643,000 |
| Total Liabilities | 59,168,000 | 62,507,000 | 69,490,000 | 76,453,000 | 85,208,000 | 89,742,000 | 102,575,000 | 116,486,000 | 139,770,000 |
| Shares Outstanding | 37,647,057 | 37,620,668 | 37,546,751 | 37,533,136 | 37,382,478 | 37,418,470 | 37,432,832 | 37,459,853 | 37,468,078 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 37,581,094 | 37,251,050 | 37,349,449 | 37,156,979 | 37,019,027 | 33,027,889 | 36,766,309 | 36,625,291 | 21,137,868 |
| Weighted Avg Shares Basic | 37,581,094 | 37,251,050 | 37,349,449 | 37,156,979 | 37,019,027 | 33,027,889 | 36,766,309 | 36,625,291 | 21,137,868 |
Audit Trail
NCAV Audit
Official-source inputs remain linked to filing provenance. Derived values are labeled as such.
| Input | Value | Source concept | Filing period | Confidence | Provenance |
|---|---|---|---|---|---|
| Current Assets | 144,558,000USD | us-gaap:AssetsCurrent | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001785279/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001785279\companyfacts.json |
| Total Liabilities | 59,168,000USD | us-gaap:Liabilities | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001785279/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001785279\companyfacts.json |
| Cash | 25,306,000USD | us-gaap:CashAndCashEquivalentsAtCarryingValue | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001785279/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001785279\companyfacts.json |
| Shares Outstanding | 37,647,057 | us-gaap:CommonStockSharesOutstanding | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001785279/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001785279\companyfacts.json |
| NCAV | 85,390,000USD | derived | 2026-03-31 | n/a | company-evidence-v1 | total_current_assets - total_liabilities |
| NCAV per share | 2.27USD | derived | 2026-03-31 | n/a | company-evidence-v1 | NCAV / shares_outstanding |
| Margin of Safety | 44.4% | derived | 2026-03-31 | n/a | gnni_publication_pack | internal_discount |
NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding
Source Provenance
- Data Source
- Data Vault
- Data Vault Root
- D:\Projects\The Data Vault
- CIK
- 0001785279
- Company ID
- n/a
- Selected Annual Source
- D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001785279\companyfacts.json
- Selected Quarterly Source
- D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001785279\companyfacts.json
- Statement Extractor
- companyfacts-screener-v1
- View Extractor
- companyfacts-screener-v1
- Source Accession Count
- 10
- Imported At
- 2026-07-04T23:04:34+00:00
- Rendered At
- 2026-07-05T09:06:29+00:00
Run Audit
- Mary Run
- 1ec055d81d1a42a39490a83bb9e1f22f
- Mary As Of
- 2026-07-03
- Accession
- 0001193125-26-216774
- CIK
- 0001785279
- Mary Filing Date
- 2026-05-11
- Filing Currency
- USD
- Internal Discount
- 44.4%
- Source State
- Verified
- Market Context
- Not Displayed
- Market Policy
- internal_only_not_redistributed
- Share Trend
- Not Evaluated
- Dilution
- Needs Review
mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-11; mary_accession=0001193125-26-216774; mary_cik=0001785279; gnni_supporting_filing_date=2026-05-11; internal_discount=0.444487; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.